Atika Capital Management »

Cymabay Therapeutics shares owned by Atika Capital Management

Quarter-by-quarter ownership of Cymabay Therapeutics shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Cymabay Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cymabay Therapeutics held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cymabay Therapeutics by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $1.7M 116k 14.91

More positions owned by Atika Capital Management

Sentinelone Cl A Call Option (S)
Five9 Call Option (FIVN)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Inspire Med Sys (INSP)
Microsoft Corporation (MSFT)
Shockwave Med (SWAV)
MercadoLibre (MELI)
Impinj (PI)
Liberty Media Corp Del Com Lbty One S C (FWONK)
Meta Platforms Cl A (META)
Vertiv Holdings Com Cl A (VRT)
Celsius Hldgs Com New (CELH)
Sherwin-Williams Company (SHW)
Adobe Systems Incorporated (ADBE)
Eli Lilly & Co. (LLY)

View all positions for Atika Capital Management

Top funds holding Cymabay Therapeutics

venBio Select Advisor
RA Capital Management
Vanguard Group
Henderson Group
T. Rowe Price Associates
Perceptive Advisors
Franklin Resources
Holocene Advisors
Octagon Capital Advisors
Point72 Asset Management
Fred Alger Management
Cormorant Asset Management
First Turn Management
Deutsche Bank Aktiengesellschaft
Lord, Abbett & Co

View all funds holding Cymabay Therapeutics